Incretins and thiazolidinediones in glucose homeostasis and cancer

Role of common polymorphisms

Shitij Arora, Anurag Mehrotra, Subhash C. Gulati

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

With growing epidemiologic and molecular evidence linking the pathogenesis of diabetes mellitus and oncogenesis, the role of anti-diabetic drugs as antineoplastic agents becomes a subject of intense investigation. Several trials are underway assessing the effect of adding metformin to the existing chemotherapy regimen in the treatment of cancers. This review has a focus on other commonly used drugs classified into two broad groups, incretins and thiazolidinediones. The aim of this review is to discuss the common genetic polymorphisms implicated in the pathogenesis of type 2 diabetes mellitus (type 2 DM) and how they are linked to molecular pathways involved in carcinogenesis.

Original languageEnglish (US)
Pages (from-to)128-134
Number of pages7
JournalCancer Letters
Volume323
Issue number2
DOIs
StatePublished - Oct 28 2012
Externally publishedYes

Fingerprint

Incretins
Thiazolidinediones
Carcinogenesis
Homeostasis
Glucose
Metformin
Genetic Polymorphisms
Pharmaceutical Preparations
Antineoplastic Agents
Type 2 Diabetes Mellitus
Neoplasms
Diabetes Mellitus
Drug Therapy
Therapeutics

Keywords

  • Oncogenesis
  • PPARγ
  • Thiazolidinediones
  • Transcription factor 7 like 2

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Incretins and thiazolidinediones in glucose homeostasis and cancer : Role of common polymorphisms. / Arora, Shitij; Mehrotra, Anurag; Gulati, Subhash C.

In: Cancer Letters, Vol. 323, No. 2, 28.10.2012, p. 128-134.

Research output: Contribution to journalArticle

Arora, Shitij ; Mehrotra, Anurag ; Gulati, Subhash C. / Incretins and thiazolidinediones in glucose homeostasis and cancer : Role of common polymorphisms. In: Cancer Letters. 2012 ; Vol. 323, No. 2. pp. 128-134.
@article{03d1da24890b475f88e5b75e4de83d94,
title = "Incretins and thiazolidinediones in glucose homeostasis and cancer: Role of common polymorphisms",
abstract = "With growing epidemiologic and molecular evidence linking the pathogenesis of diabetes mellitus and oncogenesis, the role of anti-diabetic drugs as antineoplastic agents becomes a subject of intense investigation. Several trials are underway assessing the effect of adding metformin to the existing chemotherapy regimen in the treatment of cancers. This review has a focus on other commonly used drugs classified into two broad groups, incretins and thiazolidinediones. The aim of this review is to discuss the common genetic polymorphisms implicated in the pathogenesis of type 2 diabetes mellitus (type 2 DM) and how they are linked to molecular pathways involved in carcinogenesis.",
keywords = "Oncogenesis, PPARγ, Thiazolidinediones, Transcription factor 7 like 2",
author = "Shitij Arora and Anurag Mehrotra and Gulati, {Subhash C.}",
year = "2012",
month = "10",
day = "28",
doi = "10.1016/j.canlet.2012.04.002",
language = "English (US)",
volume = "323",
pages = "128--134",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Incretins and thiazolidinediones in glucose homeostasis and cancer

T2 - Role of common polymorphisms

AU - Arora, Shitij

AU - Mehrotra, Anurag

AU - Gulati, Subhash C.

PY - 2012/10/28

Y1 - 2012/10/28

N2 - With growing epidemiologic and molecular evidence linking the pathogenesis of diabetes mellitus and oncogenesis, the role of anti-diabetic drugs as antineoplastic agents becomes a subject of intense investigation. Several trials are underway assessing the effect of adding metformin to the existing chemotherapy regimen in the treatment of cancers. This review has a focus on other commonly used drugs classified into two broad groups, incretins and thiazolidinediones. The aim of this review is to discuss the common genetic polymorphisms implicated in the pathogenesis of type 2 diabetes mellitus (type 2 DM) and how they are linked to molecular pathways involved in carcinogenesis.

AB - With growing epidemiologic and molecular evidence linking the pathogenesis of diabetes mellitus and oncogenesis, the role of anti-diabetic drugs as antineoplastic agents becomes a subject of intense investigation. Several trials are underway assessing the effect of adding metformin to the existing chemotherapy regimen in the treatment of cancers. This review has a focus on other commonly used drugs classified into two broad groups, incretins and thiazolidinediones. The aim of this review is to discuss the common genetic polymorphisms implicated in the pathogenesis of type 2 diabetes mellitus (type 2 DM) and how they are linked to molecular pathways involved in carcinogenesis.

KW - Oncogenesis

KW - PPARγ

KW - Thiazolidinediones

KW - Transcription factor 7 like 2

UR - http://www.scopus.com/inward/record.url?scp=84863091302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863091302&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2012.04.002

DO - 10.1016/j.canlet.2012.04.002

M3 - Article

VL - 323

SP - 128

EP - 134

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -